Tao Yuan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tao Yuan has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Weigang Zhao
Department of Endocrinology, Key Laboratory of Endocrinology of Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People’s Republic of China
15 shared publications Yong Fu
Department of Endocrinology, Key Laboratory of Endocrinology of Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, People's Republic of China
12 shared publicationsYingyue Dong
Department of Endocrinology, Key Laboratory of Endocrinology of Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, People’s Republic of China
9 shared publicationsAiling Wang
National Center for Women and Children’s Health, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of China
8 shared publicationsJing Zhang
Department of Laboratory, Haidian District Maternal and Child Health Care Hospital, Beijing, People’s Republic of China
8 shared publicationsJiyu Xu
Core Facility of Instrument, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, People’s Republic of China
8 shared publications
Latest Publications
- Open Access
- 1 February 2026
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 19, 1-17
Postprandial Glycemic Impact of Meal Timing and Staple Type in Outpatients with Dysglycemia: A Pilot Study Under a Streamlined and Real-World Framework
Objective: Effectively managing postprandial blood glucose is significant for impaired glucose tolerance (IGT) and type 2 diabetes mellitus (T2DM). We developed a streamlined and real-world framework and evaluated how meal timing and staple food type affect postprandial glycemic responses (PPGRs) and the influencing factors on inter-individual differences of PPGR. Materials and methods: We conducted a prospective observational study involving 33 patients with IGT and T2DM. Over a 1-week free-living period, participants completed 7 standardized meal tests: glucose solutions at breakfast, lunch, and dinner; steamed bread, rice, noodles, and oats at lunch. Linear mixed-effects models were used to compare PPGR differences of meal timing and staple food type effects. Linear regression models were applied to explore factors influencing inter-individual heterogeneity in PPGRs. Results: Participants deemed the framework simple and well tolerated. Meal timing had no significant effect on PPGR at 120 minutes (time effect P = 0.110) or 180 minutes (time effect P = 0.097). HOMA-IR was positively associated with the meal timing variability index (adjusted: β = 9.10, 95% CI: 3.01– 15.20, P = 0.005). Staple food types affected 120- and 180-minute incremental area under the curve (iAUC), relative peak glucose, and glucose fluctuation amplitude (staple food type effect P < 0.001), but had no significant effects on time to peak or coefficient of variation (staple food type effect P > 0.05). Those born in northern China had a significantly higher refined staple food sensitivity index (adjusted: β = 267.14, 95% CI: 59.18– 475.09, P = 0.014). Conclusion: The framework enables convenient, outpatient-based assessment of PPGRs and is highly acceptable to patients. We need to focus not only on the group-level general characteristics of PPGRs but also analyze their individual-level heterogeneity; this emphasizes the critical role of personalized nutrition.
- 1 February 2026
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 19, 1-17
Open AccessPostprandial Glycemic Impact of Meal Timing and Staple Type in Outpatients with Dysglycemia: A Pilot Study Under a Streamlined and Real-World Framework
Objective: Effectively managing postprandial blood glucose is significant for impaired glucose tolerance (IGT) and type 2 diabetes mellitus (T2DM). We developed a streamlined and real-world framework and evaluated how meal timing and staple food type affect postprandial glycemic responses (PPGRs) and the influencing factors on inter-individual differences of PPGR. Materials and methods: We conducted a prospective observational study involving 33 patients with IGT and T2DM. Over a 1-week free-living period, participants completed 7 standardized meal tests: glucose solutions at breakfast, lunch, and dinner; steamed bread, rice, noodles, and oats at lunch. Linear mixed-effects models were used to compare PPGR differences of meal timing and staple food type effects. Linear regression models were applied to explore factors influencing inter-individual heterogeneity in PPGRs. Results: Participants deemed the framework simple and well tolerated. Meal timing had no significant effect on PPGR at 120 minutes (time effect P = 0.110) or 180 minutes (time effect P = 0.097). HOMA-IR was positively associated with the meal timing variability index (adjusted: β = 9.10, 95% CI: 3.01– 15.20, P = 0.005). Staple food types affected 120- and 180-minute incremental area under the curve (iAUC), relative peak glucose, and glucose fluctuation amplitude (staple food type effect P < 0.001), but had no significant effects on time to peak or coefficient of variation (staple food type effect P > 0.05). Those born in northern China had a significantly higher refined staple food sensitivity index (adjusted: β = 267.14, 95% CI: 59.18– 475.09, P = 0.014). Conclusion: The framework enables convenient, outpatient-based assessment of PPGRs and is highly acceptable to patients. We need to focus not only on the group-level general characteristics of PPGRs but also analyze their individual-level heterogeneity; this emphasizes the critical role of personalized nutrition.
- Open Access
- 6 November 2025
- Published by Springer Nature in Endocrine
- Vol. 90 (3) , 1201-1220
Establishment of an accurate prediction system for gestational diabetes mellitus based on the characteristics of metabolic kinetics in early pregnancy: a prospective two-center cohort study in population according to IOM criteria
Objective To develop an accurate prediction system for gestational diabetes mellitus (GDM) in women adhering to Institute of Medicine (IOM) weight gain criteria by analyzing early-pregnancy metabolic kinetics and identifying independent risk factors. Methods A prospective two-center cohort study enrolled 1,031 pregnant women meeting IOM guidelines. Clinical, anthropometric, and metabolic parameters (pre-pregnancy BMI, lipid profiles, inflammatory markers) were collected at 6–12 weeks of gestation. Machine learning models were trained on seven core variables identified via logistic regression, with performance evaluated by AUC, sensitivity, and specificity. Results The GDM group (n = 279) exhibited significantly higher pre-pregnancy weight, BMI, triglycerides (1.21 vs. 0.96 mmol/L, p < 0.001), and inflammatory markers. Multivariate analysis identified parity ≥ 2 (OR = 4.37), family diabetes history (OR = 1.64), third-trimester weight (OR = 1.13), and triglycerides (OR = 1.49) as independent predictors. A neural network model achieved the highest AUC (0.732) with 65.1% sensitivity and 68.9% specificity, outperforming logistic regression and other algorithms. Dynamic weight trajectories and lipid dysregulation were critical risk drivers, even in IOM-compliant women. Conclusion In pregnant women adhering to IOM weight gain standards, early-pregnancy metabolic dysfunctionand specific weight trajectories persist as pivotal GDM predictors. Our neural network model integrating seven core variables—including triglyceride levels, dynamic weight patterns (6–10 weeks and 24–28 weeks), and clinical risk factors—achieved superior prediction accuracy compared to conventional weight-centric approaches. This system enables early risk stratification and personalized interventions during the first trimester, addressing a critical gap in prenatal care for guideline-compliant populations at residual GDM risk.
- 6 November 2025
- Published by Springer Nature in Endocrine
- Vol. 90 (3) , 1201-1220
Open AccessEstablishment of an accurate prediction system for gestational diabetes mellitus based on the characteristics of metabolic kinetics in early pregnancy: a prospective two-center cohort study in population according to IOM criteria
Objective To develop an accurate prediction system for gestational diabetes mellitus (GDM) in women adhering to Institute of Medicine (IOM) weight gain criteria by analyzing early-pregnancy metabolic kinetics and identifying independent risk factors. Methods A prospective two-center cohort study enrolled 1,031 pregnant women meeting IOM guidelines. Clinical, anthropometric, and metabolic parameters (pre-pregnancy BMI, lipid profiles, inflammatory markers) were collected at 6–12 weeks of gestation. Machine learning models were trained on seven core variables identified via logistic regression, with performance evaluated by AUC, sensitivity, and specificity. Results The GDM group (n = 279) exhibited significantly higher pre-pregnancy weight, BMI, triglycerides (1.21 vs. 0.96 mmol/L, p < 0.001), and inflammatory markers. Multivariate analysis identified parity ≥ 2 (OR = 4.37), family diabetes history (OR = 1.64), third-trimester weight (OR = 1.13), and triglycerides (OR = 1.49) as independent predictors. A neural network model achieved the highest AUC (0.732) with 65.1% sensitivity and 68.9% specificity, outperforming logistic regression and other algorithms. Dynamic weight trajectories and lipid dysregulation were critical risk drivers, even in IOM-compliant women. Conclusion In pregnant women adhering to IOM weight gain standards, early-pregnancy metabolic dysfunctionand specific weight trajectories persist as pivotal GDM predictors. Our neural network model integrating seven core variables—including triglyceride levels, dynamic weight patterns (6–10 weeks and 24–28 weeks), and clinical risk factors—achieved superior prediction accuracy compared to conventional weight-centric approaches. This system enables early risk stratification and personalized interventions during the first trimester, addressing a critical gap in prenatal care for guideline-compliant populations at residual GDM risk.
- Open Access
- 1 October 2025
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 18, 3967-3984
The Role of METS-IR in Early Screening for Gestational Diabetes Mellitus in Chinese Women: A Two-Center Prospective Study
Objective: This two-center prospective cohort study aimed to evaluate the predictive value of the Metabolic Score for Insulin Resistance (METS-IR) for gestational diabetes mellitus (GDM) in Chinese women during early pregnancy and compare its performance with conventional insulin resistance (IR) indices. Methods: This prospective investigation evaluated 1450 Chinese gravidas (< 12 gestational weeks) without pregestational diabetes from two obstetrical institutions. Baseline clinical-biochemical profiling occurred during the first trimester (6– 12 weeks), with GDM confirmation via standardized 75g oral glucose tolerance testing at 24– 28 weeks’ gestation. Analytical methodologies incorporated multivariable regression modeling and ROC curve optimization to quantify the predictive validity of five metabolic indices (METS-IR, TyG index, TG/HDL-C ratio, HOMA-IR, TyG-BMI) for GDM risk stratification. Results: Among participants, 378 (26.1%) developed GDM. The GDM group (n=378, 26.1%) was older (median age 31.0 vs 30.0 years, p< 0.0001) and had higher prepregnancy BMI (22.62 vs 21.32 kg/m², p< 0.0001), fasting glucose (4.7 vs 4.5 mmol/L, p< 0.0001) compared to NGT. The GDM group exhibited significantly higher METS-IR (31.14 vs 29.03, p < 0.001) and other IR indices (p < 0.001). In unadjusted models, METS-IR quartile 4 (Q4) was strongly associated with GDM (OR=3.33, 95% CI:2.38– 4.70), but this association attenuated after adjusting for age, weight gain, lipids, and insulin (adjusted OR=1.56, 95% CI:1.04– 2.35). Comparatively, the TyG index (adjusted OR=3.06, 95% CI:2.03– 4.66) and TG/HDL-C ratio (adjusted OR=2.02, 95% CI:1.38– 2.99) retained robust predictive power. ROC analysis revealed a moderate discriminative capacity for METS-IR (AUC=0.629 unadjusted; 0.676 fully adjusted), outperformed by HOMA-IR (AUC=0.699) and TyG (AUC=0.699). METS-IR demonstrated high specificity (76.2%) in unadjusted screening but showed dependency on metabolic confounders in adjusted models. Conclusion: METS-IR shows promise for early GDM screening and is outperformed by TyG and HOMA-IR in predictive value. METS-IR in early pregnancy reflects metabolic dysregulation linked to GDM risk, yet its predictive utility is partially mediated by lipid and insulin abnormalities. While METS-IR offers clinical feasibility through routine measurements, TyG and HOMA-IR exhibit superior independent predictive value. These findings highlight the importance of context-specific IR indices for early GDM risk stratification and underscore METS-IR’s role as a composite marker of metabolically unhealthy obesity in pregnancy.
- 1 October 2025
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 18, 3967-3984
Open AccessThe Role of METS-IR in Early Screening for Gestational Diabetes Mellitus in Chinese Women: A Two-Center Prospective Study
Objective: This two-center prospective cohort study aimed to evaluate the predictive value of the Metabolic Score for Insulin Resistance (METS-IR) for gestational diabetes mellitus (GDM) in Chinese women during early pregnancy and compare its performance with conventional insulin resistance (IR) indices. Methods: This prospective investigation evaluated 1450 Chinese gravidas (< 12 gestational weeks) without pregestational diabetes from two obstetrical institutions. Baseline clinical-biochemical profiling occurred during the first trimester (6– 12 weeks), with GDM confirmation via standardized 75g oral glucose tolerance testing at 24– 28 weeks’ gestation. Analytical methodologies incorporated multivariable regression modeling and ROC curve optimization to quantify the predictive validity of five metabolic indices (METS-IR, TyG index, TG/HDL-C ratio, HOMA-IR, TyG-BMI) for GDM risk stratification. Results: Among participants, 378 (26.1%) developed GDM. The GDM group (n=378, 26.1%) was older (median age 31.0 vs 30.0 years, p< 0.0001) and had higher prepregnancy BMI (22.62 vs 21.32 kg/m², p< 0.0001), fasting glucose (4.7 vs 4.5 mmol/L, p< 0.0001) compared to NGT. The GDM group exhibited significantly higher METS-IR (31.14 vs 29.03, p < 0.001) and other IR indices (p < 0.001). In unadjusted models, METS-IR quartile 4 (Q4) was strongly associated with GDM (OR=3.33, 95% CI:2.38– 4.70), but this association attenuated after adjusting for age, weight gain, lipids, and insulin (adjusted OR=1.56, 95% CI:1.04– 2.35). Comparatively, the TyG index (adjusted OR=3.06, 95% CI:2.03– 4.66) and TG/HDL-C ratio (adjusted OR=2.02, 95% CI:1.38– 2.99) retained robust predictive power. ROC analysis revealed a moderate discriminative capacity for METS-IR (AUC=0.629 unadjusted; 0.676 fully adjusted), outperformed by HOMA-IR (AUC=0.699) and TyG (AUC=0.699). METS-IR demonstrated high specificity (76.2%) in unadjusted screening but showed dependency on metabolic confounders in adjusted models. Conclusion: METS-IR shows promise for early GDM screening and is outperformed by TyG and HOMA-IR in predictive value. METS-IR in early pregnancy reflects metabolic dysregulation linked to GDM risk, yet its predictive utility is partially mediated by lipid and insulin abnormalities. While METS-IR offers clinical feasibility through routine measurements, TyG and HOMA-IR exhibit superior independent predictive value. These findings highlight the importance of context-specific IR indices for early GDM risk stratification and underscore METS-IR’s role as a composite marker of metabolically unhealthy obesity in pregnancy.
- 24 September 2025
- Published by Elsevier in The Journal of Nutrition
- Vol. 155 (12) , 4193-4208
Dynamic Prediction of Postprandial Glycemic Response and Personalized Dietary Interventions Based on Machine Learning
- 24 September 2025
- Published by Elsevier in The Journal of Nutrition
- Vol. 155 (12) , 4193-4208
Dynamic Prediction of Postprandial Glycemic Response and Personalized Dietary Interventions Based on Machine Learning
- Top Cited PapersOpen Access
- 4 February 2025
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 68 (1) , e20
Neuropsychiatric adverse events associated with Glucagon-like peptide-1 receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System database
Background: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used due to their profound efficacy in glycemic control and weight management. Real-world observations have revealed potential neuropsychiatric adverse events (AEs) associated with GLP-1RAs. This study aimed to comprehensively investigate and characterize these neuropsychiatric AEs with GLP-1RAs. Methods: We analyzed GLP-1RA adverse reaction reports using the FDA Adverse Event Reporting System database. Disproportionality analysis using reporting odds ratio (ROR) identified eight categories of neuropsychiatric AEs associated with GLP-1RAs. We conducted descriptive and time-to-onset (TTO) analyses and explored neuropsychiatric AE signals among individual GLP-1RAs for weight loss and diabetes mellitus (DM) indications. Results: We identified 25,110 cases of GLP-1RA-related neuropsychiatric AEs. GLP-1RAs showed an association with headache (ROR 1.74, 95% confidence interval [CI] 1.65–1.84), migraine (ROR 1.28, 95%CI 1.06–1.55), and olfactory and sensory nerve abnormalities (ROR 2.44, 95%CI 1.83–3.25; ROR 1.69, 95%CI 1.54–1.85). Semaglutide showed a moderate suicide-related AEs signal in the weight loss population (ROR 2.55, 95%CI 1.97–3.31). The median TTO was 16 days (interquartile range: 3–66 days). Conclusions: In this study, we identified eight potential neuropsychiatric adverse events (AEs) associated with GLP-1RAs and, for the first time, detected positive signals for migraine, olfactory abnormalities, and sensory abnormalities. We also observed positive suicide-related signals of semaglutide, in weight loss population. This study provides a reliable basis for further investigation of GLP-1RA-related neuropsychiatric AEs. However, as an exploratory study, our findings require confirmation through large-scale prospective studies.
- 4 February 2025
- Published by Royal College of Psychiatrists in European Psychiatry
- Vol. 68 (1) , e20
Top Cited PapersOpen AccessNeuropsychiatric adverse events associated with Glucagon-like peptide-1 receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System database
Background: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used due to their profound efficacy in glycemic control and weight management. Real-world observations have revealed potential neuropsychiatric adverse events (AEs) associated with GLP-1RAs. This study aimed to comprehensively investigate and characterize these neuropsychiatric AEs with GLP-1RAs. Methods: We analyzed GLP-1RA adverse reaction reports using the FDA Adverse Event Reporting System database. Disproportionality analysis using reporting odds ratio (ROR) identified eight categories of neuropsychiatric AEs associated with GLP-1RAs. We conducted descriptive and time-to-onset (TTO) analyses and explored neuropsychiatric AE signals among individual GLP-1RAs for weight loss and diabetes mellitus (DM) indications. Results: We identified 25,110 cases of GLP-1RA-related neuropsychiatric AEs. GLP-1RAs showed an association with headache (ROR 1.74, 95% confidence interval [CI] 1.65–1.84), migraine (ROR 1.28, 95%CI 1.06–1.55), and olfactory and sensory nerve abnormalities (ROR 2.44, 95%CI 1.83–3.25; ROR 1.69, 95%CI 1.54–1.85). Semaglutide showed a moderate suicide-related AEs signal in the weight loss population (ROR 2.55, 95%CI 1.97–3.31). The median TTO was 16 days (interquartile range: 3–66 days). Conclusions: In this study, we identified eight potential neuropsychiatric adverse events (AEs) associated with GLP-1RAs and, for the first time, detected positive signals for migraine, olfactory abnormalities, and sensory abnormalities. We also observed positive suicide-related signals of semaglutide, in weight loss population. This study provides a reliable basis for further investigation of GLP-1RA-related neuropsychiatric AEs. However, as an exploratory study, our findings require confirmation through large-scale prospective studies.
- Open Access
- 29 November 2024
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 15, 1427925
Thyroid FT4-to-TSH ratio in the first trimester is associated with gestational diabetes mellitus in women carrying male fetus: a prospective bi-center cohort study
Background: Gestational diabetes mellitus (GDM) is one of the most common medical complications of pregnancy, which increases the risk of other pregnant complications and adverse perinatal outcomes. Thyroid dysfunction is closely with the risk of diabetes mellitus. However, the relationship between euthyroid function in early pregnancy and GDM is still controversial.Aims: This study was to find the relationship between thyroid function within normal range during early pregnancy as well as glucose and lipids metabolisms as well as the risk of subsequent GDM.Methods: A total of 1486 pregnant women were included in this prospective double-center cohort study. Free thyroxine (FT4), thyroid stimulating hormone (TSH) and antithyroid peroxidase antibodies (TPOAb) were tested during 6-12 weeks of gestation and oral glucose tolerance test (OGTT) was conducted during 24-28 weeks to screen GDM. Relative risks (RR) with 95% confidence intervals (CI) for subsequent risk of GDM by thyroid function quartiles were assessed adjusting for major risk factors.Results: The incidence of GDM was 23.0% (342/1486). TSH, FT4 and the percentage of positive TPOAb were no significant difference between women with and without GDM, but FT4/TSH ratio was significantly higher in GDM group compared with NGT group [6.97(0.84,10.61) vs. 4.88(0.66,12.44), P=0.025)]. The linear trends of TC, TG, HDL-C, LDL-C, fasting glucose in the first trimester, insulin, C-peptide, HOMA-IR, fasting glucose during OGTT and incidence of GDM according to FT4/TSH ratio were all statistically significant. Further analysis based on fetal sex presented only the third quartile of FT4/TSH ratio in women carrying male fetus was associated with higher incidence of GDM statistically significant [RR (95% CI), 1.917 (1.143,3.216)], rather than in women carrying female fetus.Conclusions: Thyroid function even in normal range is closely related to glucose and lipids metabolisms during the first trimester. Unappropriated FT4/TSH ratio in the first trimester is an independent risk factor of GDM in women carrying male fetus.
- 29 November 2024
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 15, 1427925
Open AccessThyroid FT4-to-TSH ratio in the first trimester is associated with gestational diabetes mellitus in women carrying male fetus: a prospective bi-center cohort study
Background: Gestational diabetes mellitus (GDM) is one of the most common medical complications of pregnancy, which increases the risk of other pregnant complications and adverse perinatal outcomes. Thyroid dysfunction is closely with the risk of diabetes mellitus. However, the relationship between euthyroid function in early pregnancy and GDM is still controversial.Aims: This study was to find the relationship between thyroid function within normal range during early pregnancy as well as glucose and lipids metabolisms as well as the risk of subsequent GDM.Methods: A total of 1486 pregnant women were included in this prospective double-center cohort study. Free thyroxine (FT4), thyroid stimulating hormone (TSH) and antithyroid peroxidase antibodies (TPOAb) were tested during 6-12 weeks of gestation and oral glucose tolerance test (OGTT) was conducted during 24-28 weeks to screen GDM. Relative risks (RR) with 95% confidence intervals (CI) for subsequent risk of GDM by thyroid function quartiles were assessed adjusting for major risk factors.Results: The incidence of GDM was 23.0% (342/1486). TSH, FT4 and the percentage of positive TPOAb were no significant difference between women with and without GDM, but FT4/TSH ratio was significantly higher in GDM group compared with NGT group [6.97(0.84,10.61) vs. 4.88(0.66,12.44), P=0.025)]. The linear trends of TC, TG, HDL-C, LDL-C, fasting glucose in the first trimester, insulin, C-peptide, HOMA-IR, fasting glucose during OGTT and incidence of GDM according to FT4/TSH ratio were all statistically significant. Further analysis based on fetal sex presented only the third quartile of FT4/TSH ratio in women carrying male fetus was associated with higher incidence of GDM statistically significant [RR (95% CI), 1.917 (1.143,3.216)], rather than in women carrying female fetus.Conclusions: Thyroid function even in normal range is closely related to glucose and lipids metabolisms during the first trimester. Unappropriated FT4/TSH ratio in the first trimester is an independent risk factor of GDM in women carrying male fetus.
- 9 October 2024
- Published by Springer Nature in Reviews in Endocrine and Metabolic Disorders
- Vol. 26 (1) , 31-53
Clinical research progress on β-cell dysfunction in T2DM development in the Chinese population
The prevalence of type-2 diabetes mellitus (T2DM) has increased over 10-fold in the past 40 years in China, which now has the largest T2DM population in the world. Insulin resistance and β-cell dysfunction are the typical features of T2DM. Although both factors play a role, decreased β-cell function and β-cell mass are the predominant factors for progression to T2DM. Considering the differences between Chinese T2DM patients and those of other ethnicities, it is important to characterize β-cell dysfunction in Chinese patients during T2DM progression. Herein, we reviewed the studies on the relationships between β-cell function and T2DM progression in the Chinese population and discussed the differences among individuals of varying ethnicities. Meanwhile, we summarized the risk factors and current treatments of T2DM in Chinese individuals and discussed their impacts on β-cell function with the hope of identifying a better T2DM therapy. Graphic abstract Diagram of β-cell dysfunction in different ethnic subjects during T2DM and the risk factors and medications for β-cell function regulation in Chinese patients
- 9 October 2024
- Published by Springer Nature in Reviews in Endocrine and Metabolic Disorders
- Vol. 26 (1) , 31-53
Clinical research progress on β-cell dysfunction in T2DM development in the Chinese population
The prevalence of type-2 diabetes mellitus (T2DM) has increased over 10-fold in the past 40 years in China, which now has the largest T2DM population in the world. Insulin resistance and β-cell dysfunction are the typical features of T2DM. Although both factors play a role, decreased β-cell function and β-cell mass are the predominant factors for progression to T2DM. Considering the differences between Chinese T2DM patients and those of other ethnicities, it is important to characterize β-cell dysfunction in Chinese patients during T2DM progression. Herein, we reviewed the studies on the relationships between β-cell function and T2DM progression in the Chinese population and discussed the differences among individuals of varying ethnicities. Meanwhile, we summarized the risk factors and current treatments of T2DM in Chinese individuals and discussed their impacts on β-cell function with the hope of identifying a better T2DM therapy. Graphic abstract Diagram of β-cell dysfunction in different ethnic subjects during T2DM and the risk factors and medications for β-cell function regulation in Chinese patients
- Open Access
- 1 February 2024
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 17, 633-646
The Association of Hematological Parameters in Early and Middle Pregnancy with the Risk of Gestational Diabetes Mellitus
Objective: Gestational diabetes mellitus (GDM) is a condition of glucose intolerance, which may be accompanied with inflammation. The levels of hematological parameters during pregnancy can reflect inflammatory conditions in pregnant women. This study aims to describe the dynamic change of blood cell parameters from the first trimester (6– 12 weeks of gestation) to the second trimester (24– 28 weeks of gestation) and to investigate the associations of these biomarkers with the risk of GDM. Methods: This study was a prospective double-center study conducted in Beijing, China (clinical trial number: NCT03246295). Hematological parameters were tested four times during the follow-up. Logistic regression analysis and Receiver Operating Characteristic (ROC) curve analysis were used to explore the association and predictive ability of hematological parameters for GDM. Results: There were 258 of 1027 pregnant women in our study developed GDM. Among the 1027 pregnant women, white blood cells (WBC) gradually increased, and red blood cells (RBC), hemoglobin (HGB), and platelet (PLT) tended to decrease from the first trimester to second trimester. After adjusting for confounding factors, higher levels of RBC, HGB, and PLT in both early and middle pregnancy were positively associated with GDM risk, whereas the level of WBC was associated with GDM risk only in early pregnancy. WBC, RBC, HGB, and PLT in early and middle pregnancy were all correlated with fasting insulin (FINS) in early pregnancy. Conclusion: Higher levels of hematological parameters in early and middle pregnancy were associated with glucose metabolism in early pregnancy and the subsequent risk of GDM.
- 1 February 2024
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 17, 633-646
Open AccessThe Association of Hematological Parameters in Early and Middle Pregnancy with the Risk of Gestational Diabetes Mellitus
Objective: Gestational diabetes mellitus (GDM) is a condition of glucose intolerance, which may be accompanied with inflammation. The levels of hematological parameters during pregnancy can reflect inflammatory conditions in pregnant women. This study aims to describe the dynamic change of blood cell parameters from the first trimester (6– 12 weeks of gestation) to the second trimester (24– 28 weeks of gestation) and to investigate the associations of these biomarkers with the risk of GDM. Methods: This study was a prospective double-center study conducted in Beijing, China (clinical trial number: NCT03246295). Hematological parameters were tested four times during the follow-up. Logistic regression analysis and Receiver Operating Characteristic (ROC) curve analysis were used to explore the association and predictive ability of hematological parameters for GDM. Results: There were 258 of 1027 pregnant women in our study developed GDM. Among the 1027 pregnant women, white blood cells (WBC) gradually increased, and red blood cells (RBC), hemoglobin (HGB), and platelet (PLT) tended to decrease from the first trimester to second trimester. After adjusting for confounding factors, higher levels of RBC, HGB, and PLT in both early and middle pregnancy were positively associated with GDM risk, whereas the level of WBC was associated with GDM risk only in early pregnancy. WBC, RBC, HGB, and PLT in early and middle pregnancy were all correlated with fasting insulin (FINS) in early pregnancy. Conclusion: Higher levels of hematological parameters in early and middle pregnancy were associated with glucose metabolism in early pregnancy and the subsequent risk of GDM.
- Open Access
- 16 October 2023
- Published by Springer Nature in Diabetes Therapy
- Vol. 14 (12) , 2143-2157
A Simplified Screening Model to Predict the Risk of Gestational Diabetes Mellitus in Pregnant Chinese Women
Introduction This study aimed to develop a simplified screening model to identify pregnant Chinese women at risk of gestational diabetes mellitus (GDM) in the first trimester. Methods This prospective study included 1289 pregnant women in their first trimester (6–12 weeks of gestation) with clinical parameters and laboratory data. Logistic regression was performed to extract coefficients and select predictors. The performance of the prediction model was assessed in terms of discrimination and calibration. Internal validation was performed through bootstrapping (1000 random samples). Results The prevalence of GDM in our study cohort was 21.1%. Maternal age, prepregnancy body mass index (BMI), a family history of diabetes, fasting blood glucose levels, the alanine transaminase to aspartate aminotransferase ratio (ALT/AST), and the triglyceride to high-density lipoprotein cholesterol ratio (TG/HDL-C) were selected for inclusion in the prediction model. The Hosmer–Lemeshow goodness-of-fit test showed good consistency between prediction and actual observation, and bootstrapping indicated good internal performance. The area under the receiver operating characteristic curve (ROC-AUC) of the multivariate logistic regression model and the simplified clinical screening model was 0.825 (95% confidence interval [CI] 0.797–0.853, P < 0.001) and 0.784 (95% CI 0.750–0.818, P < 0.001), respectively. The performance of our prediction model was superior to that of three other published models. Conclusion We developed a simplified clinical screening model for predicting the risk of GDM in pregnant Chinese women. The model provides a feasible and convenient protocol to identify women at high risk of GDM in early pregnancy. Further validations are needed to evaluate the performance of the model in other populations. Trial Registration ClinicalTrials.gov identifier: NCT03246295.
- 16 October 2023
- Published by Springer Nature in Diabetes Therapy
- Vol. 14 (12) , 2143-2157
Open AccessA Simplified Screening Model to Predict the Risk of Gestational Diabetes Mellitus in Pregnant Chinese Women
Introduction This study aimed to develop a simplified screening model to identify pregnant Chinese women at risk of gestational diabetes mellitus (GDM) in the first trimester. Methods This prospective study included 1289 pregnant women in their first trimester (6–12 weeks of gestation) with clinical parameters and laboratory data. Logistic regression was performed to extract coefficients and select predictors. The performance of the prediction model was assessed in terms of discrimination and calibration. Internal validation was performed through bootstrapping (1000 random samples). Results The prevalence of GDM in our study cohort was 21.1%. Maternal age, prepregnancy body mass index (BMI), a family history of diabetes, fasting blood glucose levels, the alanine transaminase to aspartate aminotransferase ratio (ALT/AST), and the triglyceride to high-density lipoprotein cholesterol ratio (TG/HDL-C) were selected for inclusion in the prediction model. The Hosmer–Lemeshow goodness-of-fit test showed good consistency between prediction and actual observation, and bootstrapping indicated good internal performance. The area under the receiver operating characteristic curve (ROC-AUC) of the multivariate logistic regression model and the simplified clinical screening model was 0.825 (95% confidence interval [CI] 0.797–0.853, P < 0.001) and 0.784 (95% CI 0.750–0.818, P < 0.001), respectively. The performance of our prediction model was superior to that of three other published models. Conclusion We developed a simplified clinical screening model for predicting the risk of GDM in pregnant Chinese women. The model provides a feasible and convenient protocol to identify women at high risk of GDM in early pregnancy. Further validations are needed to evaluate the performance of the model in other populations. Trial Registration ClinicalTrials.gov identifier: NCT03246295.
- 2 October 2023
- Published by Springer Nature in Endocrine
- Vol. 83 (3) , 636-647
Relationship between serum uric acid in early pregnancy and gestational diabetes mellitus: a prospective cohort study
Purpose The association between serum uric acid (UA) and gestational diabetes mellitus (GDM) was still unclear. Serum UA levels in pregnancy differed from that in non-pregnancy. This study aimed to investigate the changes of serum UA in early pregnancy, and to explore the association of serum UA with the risk of GDM. Methods A prospective double-center study including 873 singleton pregnant women was conducted in Beijing, China since 2019 (clinical trial number: NCT03246295). Seventy-eight healthy non-pregnant women were selected to compare the changes of biomarkers in pregnancy. Spearman correlation and logistic regression analysis were performed to measure the relationship between serum UA in early pregnancy and GDM. Results The incidence of GDM in our cohort was 20.27%(177/873). Compared with non-pregnant women, serum UA and creatinine decreased significantly during early pregnancy. Serum UA concentration in early pregnancy was significantly higher in GDM women than that in normal glucose tolerance (NGT) women [217.0(192.9, 272.0) μmol/l vs. 201.9(176.0, 232.0) μmol/l, p < 0.001]. After adjusted for confounding factors, elevated serum UA remained as an independent risk factor for GDM. The risk of GDM increased when serum UA was above 240 μmol/l (adjusted OR 1.964, 95% CI 1.296–2.977, p < 0.001), and stronger relationships between serum UA and GDM were observed in pregnant women aged over 35 years old and preBMI ≥ 24 kg/m2. Conclusion The normal range of serum UA and creatinine in pregnant women were lower than those in non-pregnant women. It is essential to monitor serum UA concentrations since early pregnancy to alert and prevent GDM, especially in older and heavier pregnant women. Clinical trial number NCT03246295.
- 2 October 2023
- Published by Springer Nature in Endocrine
- Vol. 83 (3) , 636-647
Relationship between serum uric acid in early pregnancy and gestational diabetes mellitus: a prospective cohort study
Purpose The association between serum uric acid (UA) and gestational diabetes mellitus (GDM) was still unclear. Serum UA levels in pregnancy differed from that in non-pregnancy. This study aimed to investigate the changes of serum UA in early pregnancy, and to explore the association of serum UA with the risk of GDM. Methods A prospective double-center study including 873 singleton pregnant women was conducted in Beijing, China since 2019 (clinical trial number: NCT03246295). Seventy-eight healthy non-pregnant women were selected to compare the changes of biomarkers in pregnancy. Spearman correlation and logistic regression analysis were performed to measure the relationship between serum UA in early pregnancy and GDM. Results The incidence of GDM in our cohort was 20.27%(177/873). Compared with non-pregnant women, serum UA and creatinine decreased significantly during early pregnancy. Serum UA concentration in early pregnancy was significantly higher in GDM women than that in normal glucose tolerance (NGT) women [217.0(192.9, 272.0) μmol/l vs. 201.9(176.0, 232.0) μmol/l, p < 0.001]. After adjusted for confounding factors, elevated serum UA remained as an independent risk factor for GDM. The risk of GDM increased when serum UA was above 240 μmol/l (adjusted OR 1.964, 95% CI 1.296–2.977, p < 0.001), and stronger relationships between serum UA and GDM were observed in pregnant women aged over 35 years old and preBMI ≥ 24 kg/m2. Conclusion The normal range of serum UA and creatinine in pregnant women were lower than those in non-pregnant women. It is essential to monitor serum UA concentrations since early pregnancy to alert and prevent GDM, especially in older and heavier pregnant women. Clinical trial number NCT03246295.